NLM Digital Collections

Search

Start Over Subjects COVID-19 ✖Remove constraint Subjects: COVID-19

2. Maternal health: Outcomes worsened and disparities persisted during the pandemic : report to congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, October 2022
Subject(s):
COVID-19
Government Regulation
Healthcare Disparities -- statistics & numerical data
Legislation, Medical
Maternal Health -- statistics & numerical data
Maternal Mortality
Pregnancy Outcome
United States

3. Health insurance coverage and access to care for immigrants: key challenges and policy options

Publication:
Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Health Policy, December 17, 2021
Subject(s):
Emigrants and Immigrants -- statistics & numerical data
Health Equity
Health Services Accessibility
Health Policy
Health Status
Healthcare Disparities
Insurance Coverage -- statistics & numerical data
Medically Uninsured -- statistics & numerical data
COVID-19
United States

4. Routine vaccinations: adult rates vary by vaccine type and other factors : report to congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, September 2022
Subject(s):
Adult
Government Regulation
Health Expenditures -- statistics & numerical data
Healthcare Disparities -- statistics & numerical data
Legislation, Medical
Vaccination Coverage -- statistics & numerical data
COVID-19
United States

5. Racial and ethnic differences in children's mental health services in Medicaid before and during the COVID-19 pandemic

Author(s):
Ali, Mir M., (Health economist), author
West, Kristina D., author
Creedon, Timothy B., author
Publication:
Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Behavioral Health, Disability, and Aging Policy November 1, 2022
Subject(s):
Child
COVID-19
Ethnicity
Facilities and Services Utilization -- statistics & numerical data
Medicaid -- statistics & numerical data
Mental Health Services -- statistics & numerical data
Racial Groups
Telemedicine -- statistics & numerical data
United States

6. Disparities in preventive care receipt in Washington, DC, during the coronavirus pandemic: a case study

Author(s):
Taylor, Kimá Joy, author
Benatar, Sarah, author
Mitchell, Faith, 1952- author
Liu, Jackie, (Of Urban Institute), author
Alvarez Caraveo, Clara, author
Publication:
Washington, DC : Urban Institute, January 2023
Subject(s):
COVID-19
Health Equity -- economics
Health Policy
Healthcare Disparities
Preventive Health Services -- supply & distribution
District of Columbia

9. Inequities in health insurance coverage and access for Black and Hispanic adults: the impact of Medicaid expansion and the pandemic

Author(s):
Baumgartner Jesse C., author
Collins, Sara R., author
Radley, David C., author
Publication:
[New York, New York] : The Commonwealth Fund, March 2023
Subject(s):
Black or African American -- statistics & numerical data
COVID-19
Health Services Accessibility -- statistics & numerical data
Healthcare Disparities -- statistics & numerical data
Hispanic or Latino
Insurance Coverage -- statistics & numerical data
Insurance Coverage -- trends
Medicaid -- statistics & numerical data
Adult
United States

11. Funding and insurance

Author(s):
Seiler, Louise W., author
Publication:
[Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):
Federal Government
Insurance Coverage -- legislation & jurisprudence
Insurance, Long-Term Care -- economics
Long-Term Care -- economics
Long-Term Care -- legislation & jurisprudence
State Government
COVID-19
Medicaid -- economics
Medicare -- economics
Nursing Homes -- economics
Prisoners
Veterans
United States

12. Facility quality and safety

Author(s):
Brude, Sydney, author
Publication:
[Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):
Nursing Homes -- legislation & jurisprudence
Long-Term Care -- legislation & jurisprudence
Quality of Health Care -- legislation & jurisprudence
Safety -- legislation & jurisprudence
State Government
COVID-19
Licensure -- legislation & jurisprudence
Ownership
Quality of Life -- legislation & jurisprudence
Violence -- legislation & jurisprudence
United States

13. End-of-life issues

Author(s):
Seiler, Louise W., author
Publication:
[Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):
COVID-19
Federal Government
Nursing Homes -- legislation & jurisprudence
State Government
Terminal Care -- economics
Terminal Care -- legislation & jurisprudence
Advance Directives -- legislation & jurisprudence
Palliative Care -- legislation & jurisprudence
Prisoners -- legislation & jurisprudence
Tissue and Organ Procurement -- legislation & jurisprudence
Veterans -- legislation & jurisprudence
United States

15. Variation in patients’ use of, experiences with, and access to telehealth during the first year of the COVID-19 pandemic

Author(s):
Smith, Laura Barrie, author
Blavin, Fredric E., author
O'Brien, Claire, (Of Urban Institute), author
Publication:
Washington, DC : Urban Institute, March 2022
Subject(s):
COVID-19
Health Equity -- economics
Health Policy
Quality Assurance, Health Care -- statistics & numerical data
Social Mobility
Socioeconomic Factors
Telemedicine -- statistics & numerical data
United States

16. Children’s uninsurance fell between 2019 and 2021, but progress could stall when pandemic protections expire

Author(s):
Haley, Jennifer M., author
McMorrow, Stacey, author
Brown, Kristen, (Of Urban Institute), author
Long, Julia, (Of Urban Institute), author
Publication:
Washington, DC : Urban Institute, June 2022
Subject(s):
Child Health -- trends
Health Equity -- economics
Health Policy
Medically Uninsured -- statistics & numerical data
Social Mobility
COVID-19
United States
Children's Health Insurance Program (U.S.)

17. COVID-19 in nursing homes: CMS needs to continue to strengthen oversight of infection prevention and control : report to congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, September 2022
Subject(s):
COVID-19
Government Regulation
Infection Control -- legislation & jurisprudence
Legislation, Medical
Nursing Homes -- standards
United States
Centers for Medicare & Medicaid Services (U.S.)

19. Contact tracing for air travel: CDC’s data system needs substantial improvement : report to congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, July 2022
Subject(s):
Air Travel
Contact Tracing -- legislation & jurisprudence
Disease Transmission, Infectious -- legislation & jurisprudence
Government Regulation
Legislation, Medical
COVID-19
United States
Centers for Disease Control and Prevention (U.S.)

24. Number of uninsured children stabilized and improved slightly during the pandemic

Author(s):
Alker, Joan, author
Osorio, Aubrianna, author
Park, Edwin, author
Publication:
[Washington, DC] : Georgetown University Health Policy Institute, Center for Children and Families, December 2022
Subject(s):
COVID-19
Insurance Coverage -- statistics & numerical data
Medically Uninsured -- statistics & numerical data
Child
United States

25. Electronic public health reporting among non-federal acute care hospitals during the COVID-19 pandemic, 2021

Author(s):
Richwine, Chelsea J., author
Everson, Jordan, author
Patel, Vaishali, author
Publication:
Washington, DC : Office of the National Coordinator for Health Information Technology, September 2022
Subject(s):
COVID-19
Electronic Data Processing
Hospitals
Public Health Informatics
Public Reporting of Healthcare Data
United States

26. Tracking health insurance coverage in 2020-2021

Author(s):
Ruhter, Joel, author
Conmy, Ann B., author
Chu, Rose C., author
Peters, Christie, author
De Lew, Nancy, author
Sommers, Benjamine D., author
Publication:
Washington, D.C. : Assistant Secretary for Planning and Evaluation, Office of Health Policy, October 29, 2021
Subject(s):
Insurance Coverage -- statistics & numerical data
Insurance Coverage -- trends
Medically Uninsured -- statistics & numerical data
COVID-19
Surveys and Questionnaires
United States

27. Antipsychotic medication prescribing in long-term care facilities increased in the early months of the COVID-19 pandemic

Author(s):
Oliveira, Iara, author
Bianco, Martin, author
Ali, Mir M., (Health economist) author
Publication:
Washington, D.C. : Assistant Secretary for Planning and Evaluation, March 8, 2022
Subject(s):
COVID-19
Antipsychotic Agents -- therapeutic use
Inappropriate Prescribing -- trends
Long-Term Care
Nursing Homes
United States

28. Flexibilities in controlled substances prescribing and dispensing during the COVID-19 pandemic

Publication:
Washington, D.C. : Assistant Secretary for Planning and Evaluation, Office of Science & Data Policy, August 2022
Subject(s):
Controlled Substances -- supply & distribution
COVID-19
Electronic Prescribing
Federal Government
Health Services Accessibility
Opiate Substitution Treatment
State Government
United States

34. Learning from COVID-19: how pandemic-era policies for methadone prescribing could improve opioid treatment

Author(s):
Suen, Leslie W., author
Nguyen, Oanh K., author
Knight, Kelly Ray, 1969- author
Publication:
[Oakland, California] : California Health Care Foundation, April 2022
Subject(s):
COVID-19
Methadone -- therapeutic use
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Drug Prescriptions
Health Policy
California

38. Enforcement policy for viral transport media during the Coronavirus disease 2019 (COVID-19) public health emergency: guidance for commercial manufacturers, clinical laboratories, and Food and Drug Administration staff

Publication:
[Silver Spring, MD] : Center for Devices and Radiological Health, Office of Product Evaluation and Quality, July 2020
Subject(s):
Culture Media
Specimen Handling
Transportation
Virus Diseases
COVID-19
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

39. Temporary policy regarding accredited third-party certification program onsite observation and certificate duration requirements during the COVID-19 public health emergency

Publication:
[College Park, MD] : Center for Food Safety and Applied Nutrition, April 2020
Subject(s):
Accreditation -- methods
Certification -- methods
Food Safety
COVID-19
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

40. Temporary policy on repackaging or combining propofol drug products during the COVID-19 public health emergency

Publication:
[Silver Spring, MD] : Center for Drug Evaluation and Research, Office of Pharmaceutical Quality and Office of Compliance, April 2020
Subject(s):
Drug Packaging -- methods
Propofol -- supply & distribution
COVID-19
Drug Labeling
Pharmacies
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

41. Temporary policy for compounding of certain drugs for hospitalized patients by pharmacy compounders not registered as outsourcing facilities during the COVID-19 public health emergency (revised)

Publication:
[Silver Spring, MD] : Center for Drug Evaluation and Research, Office of Compliance May 21, 2020
Subject(s):
Drug Compounding -- methods
Hospitalization
Outsourced Services
Pharmacies
COVID-19
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

42. Temporary policy for compounding of certain drugs for hospitalized patients by outsourcing facilities during the COVID-19 public health emergency (revised)

Publication:
[Silver Spring, MD] : Center for Drug Evaluation and Research, May 21, 2020
Subject(s):
Drug Compounding -- methods
Hospitalization
Outsourced Services
COVID-19
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

43. Enforcement policy for clinical electronic thermometers during the Coronavirus disease 2019 (COVID-19) public health emergency: guidance for Industry and Food and Drug Administration staff

Publication:
[Silver Spring, MD] : Center for Devices and Radiological Health, Office of Product Evaluation and Quality, April 2020
Subject(s):
Thermometers -- supply & distribution
COVID-19
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

46. Policy for temporary compounding of certain alcohol-based hand sanitizer products during the public health emergency: immediately in effect guidance for industry

Publication:
[Silver Spring, MD] : Center for Drug Evaluation and Research, February 10, 2021
Subject(s):
Drug Compounding -- methods
Ethanol
Hand Sanitizers
COVID-19
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

48. Enforcement policy for infusion pumps and accessories during the Coronavirus disease 2019 (COVID-19) public health emergency: guidance for industry and Food and Drug Administration staff

Publication:
[Silver Spring, MD] : Center for Devices and Radiological Health, Office of Product Evaluation and Quality, April 2020
Subject(s):
Infusion Pumps
COVID-19
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

49. Enforcement policy for remote ophthalmic assessment and monitoring devices during the coronavirus disease 2019 (COVID-19) public health emergency: guidance for industry and Food and Drug Administration staff

Publication:
[Silver Spring, MD] : Center for Devices and Radiological Health, Office of Product Evaluation and Quality 2020
Subject(s):
Remote Consultation
Telemedicine -- instrumentation
Tonometry, Ocular -- instrumentation
Vision Tests -- instrumentation
Wireless Technology -- instrumentation
COVID-19
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

50. Temporary policy regarding non-standard PPE practices for sterile compounding by pharmacy compounders not registered as outsourcing facilities during the COVID-19 public health emergency

Publication:
[Silver Spring, MD] : Center for Drug Evaluation and Research, Office of Compliance, April 2020
Subject(s):
Drug Compounding -- methods
Personal Protective Equipment -- supply & distribution
COVID-19
Sterilization -- methods
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

51. Policy for the temporary use of portable cryogenic containers not in compliance with 21 CFR 211.94(e)(1) for oxygen and nitrogen during the COVID-19 public health emergency

Publication:
[Silver Spring, MD] : Center for Drug Evaluation and Research, April 2020
Subject(s):
Nitrogen -- supply & distribution
Oxygen -- supply & distribution
COVID-19
Nitrogen -- therapeutic use
Oxygen -- therapeutic use
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

54. Enforcement policy for non-invasive remote monitoring devices used to support patient monitoring during the coronavirus disease 2019 (COVID-19) public health emergency (revised): guidance for industry and Food and Drug Administration staff

Publication:
[Silver Spring, MD] : Center for Drug Evaluation and Research, October 2020
Subject(s):
COVID-19
Monitoring, Physiologic
Remote Sensing Technology
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

55. Temporary policy for preparation of certain alcohol-based hand sanitizer products during the public health emergency (COVID-19)

Publication:
[Silver Spring, MD] : Center for Drug Evaluation and Research, February 10, 2021
Subject(s):
Drug Compounding -- methods
Drug Compounding -- standards
Ethanol
Hand Sanitizers
COVID-19
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

56. Policy for temporary compounding of certain alcohol-based hand sanitizer products during the public health emergency: immediately in effect guidance for industry

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, February 10, 2021
Subject(s):
Drug Compounding -- methods
Drug Compounding -- standards
Ethanol
Hand Sanitizers
Methanol
COVID-19
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

57. Supplements for Approved Premarket Approval (PMA) or Humanitarian Device Exemption (HDE) Submissions During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency: guidance for industry and Food and Drug Administration staff

Publication:
Silver Spring, MD : Center for Devices and Radiological Health, May 2020
Subject(s):
Device Approval
COVID-19
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

60. Front line

Author(s):
Osborne, Terrance, artist
Publication:
[New Orleans] : Terrance Osborne, [2020]
Subject(s):
Nurses
Health Personnel
COVID-19

62. Conduct of clinical trials of medical products during the COVID-19 public health emergency: guidance for industry, investigators, and institutional review boards

Publication:
[Silver Spring, MD] : Center for Drug Evaluation and Research, August 30, 2021
Subject(s):
Clinical Trial Protocols as Topic
Clinical Trials as Topic -- methods
COVID-19
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

63. Notifying CDRH of a permanent discontinuance or interruption in manufacturing of a device under Section 506J of the FD&C Act during the COVID-19 public health emergency (revised): guidance for industry and Food and Drug Administration staff

Publication:
[Silver Spring, MD] : Center for Devices and Radiological Health, November 2020
Subject(s):
Equipment and Supplies
Manufacturing Industry
Medical Device Legislation
COVID-19
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

66. Effects of the COVID-19 public health emergency on formal meetings and user fee applications for medical devices: questions and answers (revised) : guidance for industry and Food and Drug Administration staff

Publication:
[Silver Spring, MD] : Center for Devices and Radiological Health, June 2020
Subject(s):
Device Approval
COVID-19
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

67. Enforcement policy for the Quality Standards of the Mammography Quality Standards Act during the COVID-19 public health emergency: guidance for mammography facilities, state MQSA contract partners, FDA approved MQSA accreditation bodies, and Food and Drug Administration staff

Publication:
[Silver Spring, MD] : Center for Devices and Radiological Health, December 2020
Subject(s):
Facility Regulation and Control
Mammography -- standards
COVID-19
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

68. Review timelines for applicant responses to complete response letters when a facility assessment is needed during the COVID-19 public health emergency

Publication:
[Silver Spring, MD] : Center for Drug Evaluation and Research, December 2020
Subject(s):
Correspondence as Topic
Drug Approval
Drug Industry
Facility Regulation and Control
COVID-19
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

76. The public health insurance landscape for pregnant and postpartum women: state and federal policies in 2020

Author(s):
Haley, Jennifer M., author
Johnson, Emily M., author
Hill, Ian, author
Kenney, Genevieve M., author
Thomas, Tyler W., author
Publication:
Washington, DC : Urban Institute, January 2021
Subject(s):
Medicaid
Medically Uninsured
Postpartum Period
Pregnant Women
COVID-19
United States
Children's Health Insurance Program (U.S.)
United States.

77. Closing postpartum coverage gaps and improving continuity and affordability of care through a postpartum Medicaid/CHIP extension

Author(s):
Johnson, Emily M., author
Haley, Jennifer M., author
McMorrow, Stacey, author
Kenney, Genevieve M., author
Thomas, Tyler W., author
Wang Pan, Clare, author
Wang, Robin, author
Publication:
Washington, DC : Urban Institute, January 2021
Subject(s):
Medicaid
Medically Uninsured -- statistics & numerical data
Postnatal Care
Postpartum Period
COVID-19
United States
Children's Health Insurance Program (U.S.)
United States.

82. Six months into the pandemic, 40 percent of parents with young children have experienced economic fallout: findings from the September 11–28 Coronavirus Tracking Survey

Author(s):
Waxman, Elaine, author
Gupta, Poonam, author
Gonzalez, Dulce, author
Publication:
Washington, DC : Urban Institute, December 2020
Subject(s):
Child, Preschool
COVID-19
Economic Recession
Economic Status
Food Insecurity
Parents
Unemployment
United States

83. Hospital experiences responding to the COVID-19 pandemic: results of a national pulse survey March 23–27, 2020

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, April 2020
Subject(s):
COVID-19
Disaster Planning -- organization & administration
Government Regulation
Hospitals -- supply & distribution
Surge Capacity -- statistics & numerical data
United States
United States. Department of Health and Human Services

85. Black and African American adults’ perspectives on discrimination and unfair judgment in health care

Author(s):
McDaniel, Marla, author
Richardson, Audrey, author
Gonzalez, Dulce, author
Alvarez Caraveo, Clara, author
Wagner, Laura, author
Skopec, Laura, author
Robert Wood Johnson Foundation, author.
Publication:
Washington, DC : Urban Institute, August 2021
Subject(s):
African Americans -- statistics & numerical data
COVID-19
Healthcare Disparities -- statistics & numerical data
Racism -- statistics & numerical data
United States

86. Maternal health inequities during the COVID-19 pandemic: challenges, promising advances, and opportunities to promote equitable care

Author(s):
Borroughs, Emily, author
Hill, Ian, author
Taylor, Kimá Joy, author
Benatar, Sarah, author
Haley, Jennifer M., author
Allen, Eva H., author
Coquillat, Sarah, author
Publication:
Washington, DC : Urban Institute, May 2021
Subject(s):
COVID-19
Health Status Disparities
Maternal-Child Health Services -- supply & distribution
Maternal Health -- statistics & numerical data
Racism -- statistics & numerical data
United States

87. COVID-19 vaccine attitudes among nonelderly adults who reported being unlikely to get vaccinated: a qualitative snapshot from the early vaccine rollout

Author(s):
Gonzalez, Dulce, author
Samuel-Jakubos, Haley, author
Courtot, Brigette, author
Alvarez Caraveo, Clara, author
Aarons, Joshua, author
Publication:
Washington, DC : Urban Institute, June 2021
Subject(s):
Adult -- psychology
COVID-19
COVID-19 Vaccines
Immunity, Herd
Vaccination Refusal -- psychology
United States

88. Leveraging community expertise to advance health equity: principles and strategies for effective community engagement

Author(s):
Allen, Eva H., author
Haley, Jennifer M., author
Aarons, Joshua, author
Lawrence, DaQuan, author
Publication:
Washington, DC : Urban Institute, July 2021
Subject(s):
Community Participation -- statistics & numerical data
COVID-19
Health Equity -- statistics & numerical data
Healthcare Disparities -- statistics & numerical data
United States

89. Delayed and forgone health care for nonelderly adults during the COVID-19 pandemic: findings from the September 11–28 Coronavirus Tracking Survey

Author(s):
Gonzalez, Dulce, author
Karpman, Michael, author
Kenney, Genevieve M., author
Zuckerman, Stephen, author
Publication:
Washington, DC : Urban Institute, February 2021
Subject(s):
Adult
COVID-19
Emergency Medical Services -- statistics & numerical data
Health Facility Closure -- economics
Health Services Accessibility -- statistics & numerical data
Pandemics -- statistics & numerical data
United States

90. Veterans Community Care Program: VA took action on veterans' access to care, but COVID-19 highlighted continued scheduling challenges : report to Congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, June 2021
Subject(s):
COVID-19
Community Health Services -- legislation & jurisprudence
Government Regulation
Health Workforce -- standards
United States
United States. Department of Veterans Affairs

91. Medicaid home-and community-based services: evaluating COVID-19 response could help CMS prepare for future emergencies : report to Congressional committees

Publication:
Washington, DC : United States Government Accountability Office, September 2021
Subject(s):
COVID-19
Government Regulation
Medicaid -- organization & administration
Public Health -- legislation & jurisprudence
United States
Centers for Medicare & Medicaid Services (U.S.)

92. Integrated care system in London: challenges and opportunities ahead

Author(s):
Charles, Anna, author
Naylor, Chris, author
Murray, Richard, author
Publication:
[London, England] : The King's Fund, February 2021
Subject(s):
Delivery of Health Care, Integrated -- organization & administration
Health Workforce -- organization & administration
National Health Programs -- organization & administration
COVID-19
Social Support
London
United Kingdom

96. California reached health coverage milestone with 94% of people insured in 2020, but access to care remains a challenge during the COVID-19 pandemic

Author(s):
Tan, Sean, author
Publication:
Los Angeles, CA : UCLA Center for Health Policy Research, September 2021
Subject(s):
Health Services Accessibility -- statistics & numerical data
Insurance Coverage -- statistics & numerical data
Racial Groups
COVID-19
California
United States

98. Challenges to public health reporting experienced by non-federal acute care hospitals: 2019

Author(s):
Richwine, Chelsea, author
Marshall, Carmelita, author
Jensen, Christian, 1833-1916, author
Patel, Vaishali, author
Publication:
Washington, DC : U.S. Department of Health and Human Services, Office of the National Coordinator for Health Information Technology, September 2021
Subject(s):
Health Information Interoperability
Hospitals
Information Dissemination
Mandatory Reporting
Public Health
Public Health Surveillance
COVID-19
Health Facility Size
State Government
United States
United States. Department of Health and Human Services.

99. Remote interactive evaluations of drug manufacturing and bioresearch monitoring facilities during the COVID-19 public health emergency

Publication:
[Silver Spring, MD] : Center for Drug Evaluation and Research, April 2021
Subject(s):
Consumer Product Safety
Drug Industry
Pharmaceutical Research
COVID-19
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration